ASH announces 2011 Scholar Award winners

December 20, 2010

(WASHINGTON, December 20, 2010) - The American Society of Hematology (ASH) announces the 2011 Scholar Award recipients. The program is designed to support hematologists who have chosen a career in research by providing partial salary or other support during the critical period required for completion of training and achievement of status as an independent investigator.

The awards are made possible through grants from the corporate community, individual donors, foundations, and funds committed by the Society. The awards are for a two- to three-year period, totaling $100,000 for fellows and $150,000 for junior faculty.

The 2011 Scholar Award recipients are:

Basic Research Fellow

Omar I. Abdel-Wahab, MD
Memorial Sloan-Kettering Cancer Center

Karen L. Bunting, PhD
Weill Cornell Medical College

Brian T. Edelson, MD, PhD
Washington University School of Medicine

Hiyaa S. Ghosh, MSc, PhD
Columbia University Medical Center

Andrew G. Muntean, PhD
University of Michigan

Mary Philip, MD, PhD
University of Washington

Jonathan N. Thon, PhD
Brigham and Women's Hospital

Jennifer J. Trowbridge, PhD
Dana-Farber Cancer Institute

Pieter Van Vlierberghe, PhD
Columbia University Medical Center

Basic Research Junior Faculty

Anil Chauhan, PhD
University of Iowa

Jill Johnsen, MD
University of Washington

Michael G. Kharas, PhD
Brigham and Women's Hospital

George J. Murphy, PhD
Boston University School of Medicine

Daniel T. Starczynowski, PhD
University of Cincinnati

Catherine T. Yan, PhD
Beth Israel Deaconess Medical Center

Clinical/Translational Research Fellow

Samantha M. Jaglowski, MD
The Ohio State University

Holbrook Kohrt, MD
Stanford University

Clinical/Translational Research Junior Faculty

Veronika Bachanova, MD
University of Minnesota

William Savage, MD
Johns Hopkins University

Joanne Levy, MD, Memorial Award for Outstanding Achievement

The Joanne Levy, MD, Memorial Award for Outstanding Achievement is given to the current ASH Scholar with the highest scoring abstract for the ASH annual meeting. This award is made possible by the Levy family and continues the legacy of their daughter Joanne, a past ASH Scholar Award recipient and distinguished Society member who passed away in 2004.

This year's recipient is Grant Challen, PhD, of the Baylor College of Medicine. Dr. Challen received his PhD from the University of Queensland, Australia, in 2006. After completing his doctorate, he joined the lab of Dr. Margaret Goodell at the Baylor College of Medicine in Houston, TX, to begin his postdoctoral fellowship studying the molecular regulation of hematopoietic stem cells (HSC). During this time, his biggest accomplishment has been providing some of the first evidence for the purification of lineage-biased HSCs from bone marrow.

Dr. Challen's current research focuses on the genetic and epigenetic mechanisms controlling the self-renewal and differentiation of HSCs, particularly regulation of gene expression by DNA methylation. The award will provide funding for him to continue this research.
The American Society of Hematology ( is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems by promoting research, clinical care, education, training, and advocacy in hematology. The official journal of ASH is Blood (, the most cited peer-reviewed publication in the field, which is available weekly in print and online.

American Society of Hematology

Related Hematology Articles from Brightsurf:

Study finds gender disparities in hematology research success
Hematologists who complete a mentored training program experience greater levels of academic success than those who do not; however, a study published today in Blood Advances suggests a slight discrepancy in success levels between male and female hematologists.

Survey suggests mentorship in medical school is vital to future of hematology
A survey of US hematology-oncology fellows suggests medical school plays an important role in shaping their interest in pursuing careers in hematology, particularly when students are exposed to hematology and oncology as part of core clerkships in internal medicine and pediatrics.

JAK inhibitors associated with aggressive lymphoma
Austrian researchers have discovered that a small number of patients taking targeted drugs known as Janus kinase (JAK) inhibitors to treat myelofibrosis may develop aggressive lymphomas.

For young adults with blood cancer, pediatric centers may improve survival
Adolescents and young adults with acute leukemia have a survival advantage if they receive treatment at a pediatric cancer center versus an adult center, according to a new study.

Global hematology diagnostics market estimated to expand at a robust CAGR over 2021
Hematology includes various IVD technologies such as blood analysis, flow cytometry, immunodiagnostics, molecular diagnostics, hemostasis, histology, and cytology.

Late-breaking hematology abstracts signal new, near-term therapeutic options for patients
In four clinical trials being presented today during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, researchers report promising results suggesting patients with blood disorders and several types of cancer will soon have significantly expanded options for treatment.

American Society of Hematology announces top trainee abstracts of 2016 ASH Annual Meeting
The American Society of Hematology (ASH) is pleased to recognize the following trainees with the highest-scoring abstracts in the categories of undergraduate student, medical student, graduate student, resident physician, and postdoctoral fellow at the 58th ASH Annual Meeting Dec.

ASH to expand family of blood journals with launch of new cutting-edge publication
The American Society of Hematology (ASH) will launch an open-access journal to complement Blood, its flagship publication and the most-cited journal in hematology.

Study finds common genetic variants that double risk for blood clots in African Americans
New research published online today in Blood the Journal of the American Society of Hematology, identifies common genetic variants predominantly found in African Americans that double their risk for blood clots.

Mount Sinai researchers present results at American Society of Hematology Meeting
Icahn School of Medicine at Mount Sinai researchers will present several landmark studies at the 2015 American Society of Hematology meeting Dec.

Read More: Hematology News and Hematology Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to